TapewireFind a company

person · Reporting owner

Moran Timothy P.

Disclosed activity across 3 companies

Tapewire entity
24204
SEC CIK
0001753958

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Adagio Medical Holdings, Inc.ADGM · Entity 7926DirectorJune 16, 2026August 12, 2026
KESTRA MEDICAL TECHNOLOGIES, LTD.KMTS · Entity 4686Chief Business OfficerJuly 30, 2026August 03, 2026
Motus GI Holdings, Inc.MOTS · Entity 93100DirectorMarch 05, 2024March 13, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Adagio Medical Holdings, Inc.

Report date June 16, 2026 · Filed August 12, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Non-qualified stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-06-16Direct30,000 Reported balance After 2026-06-16 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-06-16 · Grant · Acquired 30,000 · Balance 30,000

F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.

Filing footnotes · ownership attribution and instrument terms

F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.

KESTRA MEDICAL TECHNOLOGIES, LTD.

Report date July 30, 2026 · Filed August 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect66,345 Ending reported balance After 2026-08-03 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2026-07-30 · Sale · Disposed 4,117 · Balance 77,484

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Row 2 · 2026-07-31 · Sale · Disposed 8,759 · Balance 68,725

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Row 3 · 2026-08-03 · Sale · Disposed 2,380 · Balance 66,345

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Filing footnotes · ownership attribution and instrument terms

F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Motus GI Holdings, Inc.

Report date March 05, 2024 · Filed March 13, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.62 · Expires 2034-03-05Direct23,205 Reported balance After 2024-03-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-03-05 · Grant · Acquired 23,205 · Balance 23,205

F1: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 03, 2026 Filed Aug 3, 2026 23:35 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 SaleCommon Shares 2,380 $23.76 $56,551.42
Disclosure

SEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 3

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,345

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Read SEC document
July 31, 2026 Filed Aug 3, 2026 23:35 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 SaleCommon Shares 8,759 $22.61 $198,000.70
Disclosure

SEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 2

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,725

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Read SEC document
July 30, 2026 Filed Aug 3, 2026 23:35 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 SaleCommon Shares 4,117 $22.77 $93,758.50
Disclosure

SEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,484

F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.

F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Read SEC document
July 16, 2026 Filed Jul 17, 2026 21:52 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 GrantCommon Shares 39,113 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-308047 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,601

F1 · shares: Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026.

Read SEC document
June 30, 2026 Filed Jul 2, 2026 21:16 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 GrantCommon Stock 227 $21.55 $4,891.85
Disclosure

SEC source: 0001193125-26-294959 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,488

F1 · kind: Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026.

F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.

F3 · balance_after: Includes unvested RSUs.

Read SEC document
June 16, 2026 Filed Aug 12, 2026 17:30 UTC Adagio Medical Holdings, Inc. ADGM · Entity 7926 GrantNon-qualified stock option (right to buy) · Derivative 30,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001753958-26-000002 · form4-08122026_050849.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-16

F1 · security: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.

F1 · derivative.exercise_date: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.

Read SEC document
June 03, 2026 Filed Jun 4, 2026 22:40 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 GrantCommon Shares 22,704 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-257915 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,261

F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 02:48 UTC KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 GrantCommon Shares 19,557 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-25-308424 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,557

F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date.

F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 22:58 UTC Adagio Medical Holdings, Inc. ADGM · Entity 7926 GrantNon-qualified stock option (right to buy) · Derivative 90,000 $0.00 Strike: $0.87 $0.00
Disclosure

SEC source: 0001415889-25-008802 · form4-03212025_100303.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2034-07-31

F1 · security: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024.

F1 · derivative.exercise_date: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024.

Read SEC document
March 05, 2024 Filed Mar 13, 2024 01:27 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 23,205 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0001493152-24-009745 · ownership.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,205

Underlying: Common Stock, par value $0.0001 per share · 23,205 shares

Expires 2034-03-05

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:11 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.46 $0.00
Disclosure

SEC source: 0001493152-22-004067 · ownership.xml · derivative · entry 2

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock, par value $0.0001 per share · 175,000 shares

Expires 2032-02-10

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
February 10, 2022 Filed Feb 11, 2022 22:11 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantCommon Stock, par value $0.0001 per share 175,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-22-004067 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 657,701

F1 · shares: On February 10, 2022, Reporting Person was granted 175,000 Common Stock restricted stock units. The restricted stock units vest in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

Read SEC document
November 19, 2021 Filed Nov 22, 2021 13:01 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 10,000 $0.52 $5,214.00
Disclosure

SEC source: 0001213900-21-061012 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,701

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5203 to $0.5224, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 21:15 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 141,000 $0.00 Strike: $1.78 $0.00
Disclosure

SEC source: 0001213900-21-010581 · ownership.xml · derivative · entry 2

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,000

Underlying: Common Stock, par value $0.0001 per share · 141,000 shares

Expires 2031-02-17

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
February 17, 2021 Filed Feb 19, 2021 21:15 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantCommon Stock, par value $0.0001 per share 141,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-010581 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,701

F1 · shares: On February 17, 2021, Reporting Person was granted 141,000 Common Stock restricted stock units. The restricted stock units vest in substantially equal quarterly installments over three years commencing on February 17, 2021. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

Read SEC document
December 04, 2020 Filed Dec 7, 2020 14:01 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 10,000 $0.96 $9,644.00
Disclosure

SEC source: 0001213900-20-041229 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 331,701

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9634 to $0.9653, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 11, 2020 Filed Nov 13, 2020 22:33 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 190,000 $0.00 Strike: $0.74 $0.00
Disclosure

SEC source: 0001213900-20-037013 · ownership.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

Underlying: Common Stock, par value $0.0001 per share · 190,000 shares

Expires 2030-11-11

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
June 11, 2020 Filed Jun 12, 2020 20:31 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 200,000 $0.00 Strike: $1.17 $0.00
Disclosure

SEC source: 0001213900-20-014839 · ownership.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock, par value $0.0001 per share · 200,000 shares

Expires 2030-06-11

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
February 06, 2020 Filed Feb 7, 2020 21:35 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 103,720 $0.00 Strike: $2.16 $0.00
Disclosure

SEC source: 0001213900-20-002929 · ownership.xml · derivative · entry 2

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,720

Underlying: Common Stock, par value $0.0001 per share · 103,720 shares

Expires 2030-02-06

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
February 06, 2020 Filed Feb 7, 2020 21:35 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantCommon Stock, par value $0.0001 per share 103,720 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-002929 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,701

F1 · shares: On February 6, 2020, Reporting Person was granted 103,720 Common Stock restricted stock units. The restricted stock units vest in substantially equal quarterly installments over three years commencing on February 6, 2020. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").

Read SEC document
November 20, 2019 Filed Nov 20, 2019 21:30 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 10,000 $1.54 $15,400.00
Disclosure

SEC source: 0001213900-19-024215 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,981

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.58, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 20:10 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 3,333 $3.00 $9,999.00
Disclosure

SEC source: 0001213900-19-011867 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,981

F1 · kind: The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 1, 2019.

Read SEC document
May 22, 2019 Filed May 24, 2019 11:02 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 5,000 $3.38 $16,900.00
Disclosure

SEC source: 0001615774-19-008371 · s118506_form4.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,648

Read SEC document
February 13, 2019 Filed Feb 15, 2019 22:02 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 28,944 $0.00 Strike: $4.30 $0.00
Disclosure

SEC source: 0001615774-19-002645 · s116123_form4.xml · derivative · entry 2

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,944

Underlying: Common Stock, par value $0.0001 per share · 28,944 shares

Expires 2029-02-13

F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document
February 13, 2019 Filed Feb 15, 2019 22:02 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantCommon Stock, par value $0.0001 per share 174,648 $0.00 $0.00
Disclosure

SEC source: 0001615774-19-002645 · s116123_form4.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 199,648

F1 · shares: On February 13, 2019, the Reporting Person was granted 174,648 Common Stock restricted stock units. 165,000 of the restricted stock units vest in substantially equal quarterly installments over four years commencing on October 1, 2018. 9,648 of the restricted stock units vest in substantially equal quarterly installments over four years commencing on February 13, 2019. Each restricted stock unit represents a contingent right to receive one share of Common Stock.

Read SEC document
December 24, 2018 Filed Dec 26, 2018 22:08 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 10,000 $2.70 $27,000.00
Disclosure

SEC source: 0001615774-18-014977 · s114870_form4.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

F1 · kind: The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on December 24, 2018.

Read SEC document
November 19, 2018 Filed Nov 21, 2018 15:12 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 PurchaseCommon Stock, par value $0.0001 per share 15,000 $3.48 $52,200.00
Disclosure

SEC source: 0001615774-18-013097 · ownership.xml · nonDerivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.39 to $3.63, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Read SEC document
November 08, 2018 Filed Nov 9, 2018 21:30 UTC Motus GI Holdings, Inc. MOTS · Entity 93100 GrantStock Option (right to buy) · Derivative 495,000 $0.00 Strike: $3.78 $0.00
Disclosure

SEC source: 0001615774-18-012429 · ownership.xml · derivative · entry 1

Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 495,000

Underlying: Common Stock · 495,000 shares

Expires 2028-11-08

F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option vests in twelve equal quarterly installments beginning on January 1, 2019 and continuing on the first day of each third month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.